glaxo aims profit fall
glaxosmithkline profits fall drugmaker recovery
cheap copies drugs paxil wellbutrin weak dollar profits confident drug pipeline deliver profits failure obesity drug garnier difficult
afternoon pence garnier absorbed generics managing grow continuing terms pipeline progress discontinued experimental treatment obesity disappointing clinical trial glaxo relying treatments cancer diabetes depression allergies lift pace disappointing
